Back to Results
First PageMeta Content
Bristol-Myers Squibb / Entecavir / Lamivudine / Adefovir / Hepatitis B / Pharmaceutical Benefits Scheme / Medicine / Purines / Chemistry / Organic chemistry


Addendum to ACERH Research Report No.7 Original statement: Entecavir is subsidised only as a second line therapy for patients who have failed
Add to Reading List

Document Date: 2010-07-22 00:16:23

Open Document

File Size: 268,68 KB

Share Result on Facebook

Country

Australia / /

MedicalCondition

chronic hepatitis B / /

Organization

National Science Foundation / Australian Centre for Economic Research / /

Position

Butler / Governor / /

Product

lamivudine / /

RadioStation

KJR / /

URL

http /

SocialTag